Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer

Siegel, 2015, Cancer statistics, C.A. Cancer J Clin, 2015, 5, 10.3322/caac.21254 Yamamoto, 1998, Japan pancreatic cancer registry: Current status, Pancreas, 16, 238, 10.1097/00006676-199804000-00006 Ueno, 2009, A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer, Br J Cancer, 101, 908, 10.1038/sj.bjc.6605256 Loehrer, 2011, Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group Trial, J Clin Oncol, 29, 4105, 10.1200/JCO.2011.34.8904 Klaassen, 1985, Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil–an Eastern Cooperative Oncology Group study, J Clin Oncol., 3, 373, 10.1200/JCO.1985.3.3.373 Gastrointestinal Tumor Study Group, 1988, Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group, J Natl Cancer Inst, 80, 751, 10.1093/jnci/80.10.751 Krishnan, 2016, Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation, Int J Radiat Oncol Biol Phys, 94, 755, 10.1016/j.ijrobp.2015.12.003 Mahadevan, 2010, Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 78, 735, 10.1016/j.ijrobp.2009.08.046 Sachsman, 2014, Proton therapy and concomitant capecitabine for non-metastatic unresectable pancreatic adenocarcinoma, Int J Particle Ther, 1, 692, 10.14338/IJPT.14-00006.1 Grassberger, 2011, Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning, Int J Radiat Oncol Biol Phys, 80, 1559, 10.1016/j.ijrobp.2010.10.027 Koong, 2000, Pancreatic tumors show high levels of hypoxia, Int J Radiat Oncol Biol Phys, 48, 919, 10.1016/S0360-3016(00)00803-8 Kanai, 1999, Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy, Int J Radiat Oncol Biol Phys, 44, 201, 10.1016/S0360-3016(98)00544-6 Kawashiro, 2018, Multi-institutional Study of carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas, Int J Radiat Oncol Biol Phys, 101, 1212, 10.1016/j.ijrobp.2018.04.057 Bassler, 2010, Dose- and LET-painting with particle therapy, Acta Oncol., 49, 1170, 10.3109/0284186X.2010.510640 Bassler, 2014, LET-painting increases tumour control probability in hypoxic tumours, Acta Oncol, 53, 25, 10.3109/0284186X.2013.832835 Tinganelli, 2015, Kill-painting of hypoxic tumours in charged particle therapy, Sci Rep, 5, 17016, 10.1038/srep17016 United States Department of Health and Human Services. Common Terminology Criteria for Adverse Events v4.0 NIH publication 2009 https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf. [accessed14 September 2019]. Shinoto, 2013, Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer, Cancer, 119, 45, 10.1002/cncr.27723 Karger, 2017, RBE and related modeling in carbon-ion therapy, Phys Med Biol, 63, 01TR02, 10.1088/1361-6560/aa9102 Kanematsu, 2018, Estimation of linear energy transfer distribution for broad-beam carbon-ion radiotherapy at the National Institute of Radiological Sciences, Japan. Radiol Phys Technol., 11, 242, 10.1007/s12194-018-0444-7 Shinoto, 2016, Carbon ion radiation therapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys., 95, 498, 10.1016/j.ijrobp.2015.12.362